We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Technology for Sampling Body Liquids in Confined Spaces to Enable Early Cancer Detection

By LabMedica International staff writers
Posted on 17 Sep 2024
Print article
Image: Group of capsules moving in tubular tortuous structures and sampling liquids (Photo courtesy of Vanderbilt University)
Image: Group of capsules moving in tubular tortuous structures and sampling liquids (Photo courtesy of Vanderbilt University)

Body fluids—such as blood, pancreatic juice, urine, and mucus—contain valuable information about chemical composition, biomarkers, bacterial colonies, and other key components. This information aids researchers in understanding the mechanisms of various diseases, including cancer, and monitoring patients' health. Wireless mobile robots at the millimeter scale have shown promise in navigating confined spaces to collect these fluids due to their small size and agile movement. However, these devices have lacked the ability to sample liquids effectively because of the absence of efficient triggering and sealing mechanisms at such small scales. Researchers have now addressed this gap by developing technology for sampling body fluids in narrow and complex spaces, which could enable early detection of diseases like cancer.

A research team at Vanderbilt University (Nashville, TN, USA) has developed millimeter-scale soft capsules made of hydrogel-and-elastomer hybrids, which are controlled using external magnetic fields. These devices, according to the researchers, can be delivered and retrieved via a thin catheter and are capable of navigating tubular structures that are otherwise inaccessible to catheters. The soft capsules are coated with a specialized wetting property that enables them to efficiently pump liquids inside. As reported in Science Advances, the integration of on-demand triggering, sampling, and sealing mechanisms, along with agile group locomotion, allowed the team to demonstrate precise control of these soft capsules. They successfully navigated and sampled body fluids in a phantom and ex vivo animal organ, guided by ultrasound and X-ray medical imaging.

“The millimeter-scale soft capsules introduced in this work open avenues for minimally invasive and targeted liquid biopsy in confined spaces such as the pancreas duct, enabling early disease diagnosis and providing insights into disease development through the sampling, retrieval, and analysis of abundant chemicals within organs,” said Xiaoguang Dong, assistant professor of mechanical and biomedical engineering at Vanderbilt University, who led the research.

Related Links:
Vanderbilt University

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.